These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1458556)

  • 1. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
    Pan SS; Akman SA; Forrest GL; Hipsher C; Johnson R
    Cancer Chemother Pharmacol; 1992; 31(1):23-31. PubMed ID: 1458556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS; Yu F; Hipsher C
    Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.
    Pan SS; Forrest GL; Akman SA; Hu LT
    Cancer Res; 1995 Jan; 55(2):330-5. PubMed ID: 7812966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
    Hu LT; Stamberg J; Pan S
    Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
    Marshall RS; Paterson MC; Rauth AM
    Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH; Naito M; Nakajima M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
    Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
    Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
    J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
    Walton MI; Smith PJ; Workman P
    Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
    Bando T; Kasahara K; Shibata K; Numata Y; Heki U; Shirasaki H; Iwasa K; Fujimura M; Matsuda T
    J Cancer Res Clin Oncol; 1996; 122(1):21-6. PubMed ID: 8543588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins.
    Wakusawa S; Nakamura S; Miyamoto K
    Jpn J Cancer Res; 1997 Jan; 88(1):88-96. PubMed ID: 9045901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
    Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T
    Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
    Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
    Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory network of mitomycin C action in human colon cancer cells.
    Suzuki K; Yamamoto W; Park JS; Hanaoka H; Okamoto R; Kirihara Y; Yorishima T; Okamura T; Kumazaki T; Nishiyama M
    Jpn J Cancer Res; 1999 May; 90(5):571-7. PubMed ID: 10391098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.
    Yu F; Pan SS
    Mol Pharmacol; 1993 Jun; 43(6):863-9. PubMed ID: 8391116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the mechanistic aspects of mitomycin antibiotic bioactivation in Chinese hamster ovary cells overexpressing NADPH:cytochrome C (P-450) reductase and DT-diaphorase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Adv Enzyme Regul; 1998; 38():111-33. PubMed ID: 9762350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity.
    Joseph P; Xu Y; Jaiswal AK
    Int J Cancer; 1996 Jan; 65(2):263-71. PubMed ID: 8567127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.